Johns Hopkins University
OrganisationROR
People
Director of cerebral fluid center21 Sept 2026reporter.nih.gov
21 Sept 2026reporter.nih.gov
17 Sept 2026reporter.nih.gov
Professor awaiting rank24 Aug 2026reporter.nih.gov
24 Aug 2026reporter.nih.gov
Professor of Medicine11 Aug 2026assets-us-01.kc-usercontent.com
Member of
Trials
Rhythmic Entrainment and Alertness in Lewy Body Dementia
No phaseNot yet recruiting202630 people29 Sept 2026clinicaltrials.gov
Phase 2Recruiting202620 people29 Jul 2026clinicaltrials.gov
Personalized Closed-Loop Brain Stimulation for Patients With Primary Progressive Aphasia
No phaseNot yet recruiting202610 people6 Apr 2026clinicaltrials.gov
Combination Therapy for Alcohol Use Disorder
Phase 2Not yet recruiting202645 people25 Nov 2025clinicaltrials.gov
CollaboratorNo phaseActive, not recruiting202623 people19 Nov 2025clinicaltrials.gov
CollaboratorPhase 3Recruiting20261,500 people18 Nov 2025clinicaltrials.gov
CollaboratorPhase 2Not yet recruiting20263 people29 Oct 2025clinicaltrials.gov
Phase 2Recruiting2025105 people26 Feb 2025clinicaltrials.gov
Phase 3Recruiting2025150 people11 Jul 2024clinicaltrials.gov
Phase 1/2Enrolling by invitation202422 people17 Apr 2024clinicaltrials.gov
Phase 2Recruiting2024100 people22 Feb 2024clinicaltrials.gov
Phase 4Completed202329 people23 Feb 2023clinicaltrials.gov
Phase 3Active, not recruiting2023485 people13 Sept 2022clinicaltrials.gov
Phase 2/3Recruiting2023660 people9 Jun 2022clinicaltrials.gov
Sodium Lowering Vascular Effects Trial
CollaboratorNo phaseActive, not recruiting2023256 people24 May 2022clinicaltrials.gov
CollaboratorPhase 3Active, not recruiting202333 people6 May 2022clinicaltrials.gov
Deliver-EE: Evaluating Effects of Meal Delivery
CollaboratorNo phaseActive, not recruiting20222,300 people2 May 2022clinicaltrials.gov
Phase 3Recruiting202348 people3 Mar 2022clinicaltrials.gov
Early phase 1Completed20228 people10 Dec 2021clinicaltrials.gov
CollaboratorPhase 1/2Active, not recruiting202392 people17 Nov 2021clinicaltrials.gov
Grants and prizes
National Institute of Neurological Disorders and Stroke
U01A Placebo-Controlled Effectiveness in INPH Shunting (PENS) TrialU01NS122764US$30k2021–202721 Sept 2026reporter.nih.gov
NMDAR-AKT signaling and AD pathogenesisR01AG102911US$588.3k17 Sept 2026reporter.nih.gov
Memory Care in Assisted Living: Does it Improve Quality OutcomesR01AG082308US$736k24 Aug 2026reporter.nih.gov